Financials
Income statement
Fiscal date | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
---|---|---|---|---|
Total reported revenue | 5.8B | 5.9B | 7.9B | 5.8B |
Cost of revenue | 4.4B | 4.5B | 5.0B | 4.4B |
Gross profit | 1.4B | 1.4B | 2.9B | 1.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 848M | 886M | 763M | 789M |
Other operating expenses | — | — | — | — |
Operating income | 542M | 560M | 2.2B | 561M |
Non operating interest income | ||||
Income | 7M | 16M | 19M | 25M |
Expense | 377M | 403M | 431M | 450M |
Other income expense | — | — | — | — |
Pretax income | -71M | 289M | 1.7B | 96M |
Tax provision | 7M | -14M | 8M | 5M |
Net income | -78M | 303M | 1.7B | 91M |
Basic EPS | -0.1 | 0.2 | 1.4 | 0.1 |
Diluted EPS | -0.1 | 0.2 | 1.3 | 0.1 |
Basic average shares | 1.7B | 1.7B | 1.7B | 1.7B |
Diluted average shares | 1.7B | 1.8B | 1.8B | 1.7B |
EBITDA | 1.2B | 1.4B | 2.8B | 1.2B |
Net income from continuing op. | -78M | 303M | 1.7B | 91M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |